Section Arrow
NBIX.NASDAQ
- Neurocrine Biosciences
Quotes are at least 15-min delayed:2024/09/21 06:38 EDT
Last
 118.35
-2.11 (-1.75%)
Day High 
120.28 
Prev. Close
120.46 
1-M High
154.865 
Volume 
1.28M 
Bid
118.4
Ask
118.8
Day Low
117 
Open
120.28 
1-M Low
118.04 
Market Cap 
12.16B 
Currency USD 
P/E 36.28 
%Yield -- 
10-SMA 120.98 
20-SMA 128.4 
50-SMA 139.46 
52-W High 157.9799 
52-W Low 103.63 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
3.32/6.86
Enterprise Value
12.42B
Balance Sheet
Book Value Per Share
24.85
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
1.89B
Operating Revenue Per Share
17.67
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
VTRSViatris11.39-0.51-4.29%227.2PE
TLRYTilray Brands1.71-0.07-3.93%-- 
TEVATeva Pharmaceutical Industries Limited17.51-0.25-1.41%-- 
ELANElanco Animal Health14.07-1-6.64%-- 
IRWDIronwood Pharmaceuticals4.305-0.205-4.55%56.38PE
Quotes are at least 15-min delayed:2024/09/21 06:38 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.